MedPath

上海汇伦江苏药业有限公司

Ownership
-
Established
2010-12-29
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

23

NMPA:23

Drug Approvals

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字H20244459
Approval Date
Jul 16, 2024
NMPA

Sugammadex Sodium Injection

Product Name
舒更葡糖钠注射液
Approval Number
国药准字H20243562
Approval Date
Apr 24, 2024
NMPA

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字H20243514
Approval Date
Apr 17, 2024
NMPA

Sildenafil Citrate Tablets

Product Name
枸橼酸西地那非片
Approval Number
国药准字H20243513
Approval Date
Apr 17, 2024
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20247036
Approval Date
Feb 29, 2024
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20233235
Approval Date
Feb 28, 2023
NMPA

Tadalafil Tablets

Product Name
他达拉非片
Approval Number
国药准字H20233240
Approval Date
Feb 28, 2023
NMPA

Esomeprazole Sodium for Injection

Product Name
注射用艾司奥美拉唑钠
Approval Number
国药准字H20227040
Approval Date
Mar 25, 2022
NMPA

Temozolomide for Injection

Product Name
注射用替莫唑胺
Approval Number
国药准字H20213724
Approval Date
Sep 13, 2021
NMPA

Silodosin Capsules

Product Name
赛洛多辛胶囊
Approval Number
国药准字H20213612
Approval Date
Jul 28, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.